基于水凝的药物输送系统用于增强瘤治疗
Shijia Tian1,2, Shuxiang Yang1,2,3, Yanfei Liu1,2
1Key Laboratory of Cell Engineering of Guizhou Province, Affiliated Hospital of Zunyi Medical University Zunyi 563000 China l_yfei@163.com yanfei_liu@zmu.edu.cn.
RSC advances
|February 9, 2026
概括
水凝技术为癌症治疗提供了一种新的方法,它可以控制药物输送并克服传统疗法的局限性. 这些先进的水凝系统提高了治疗效率,同时减少了癌症患者的副作用.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 药物输送系统 药物输送系统
背景情况:
- 癌症给全球健康带来了重大挑战,现有的治疗方法面临毒性和耐药性等局限性.
- 瘤微环境 (TME) 通常会抑制有效的抗瘤反应.
- 水凝技术为解决这些治疗挑战提供了一个有前途的平台.
研究的目的:
- 审查用于癌症治疗的水凝应用的最新进展.
- 要突出水凝如何增强各种抗瘤策略.
- 讨论水凝在克服当前癌症治疗局限性的潜力.
主要方法:
- 对用于癌症治疗的创新水凝系统的审查.
- 对凝特性进行分析,使药物可得到控制的输送.
- 在化疗,免疫治疗,放射治疗,光疗和基因治疗中探索水凝应用.
主要成果:
- 水凝促进了高药物负载和局部,持续释放.
- 水凝系统表现出适合特定治疗需求的调节性质.
- 通过水凝进行时空控制的输送提高了治疗效率,并最大限度地减少了非目标效应.
结论:
- 水凝技术代表了癌症治疗的变革性方法.
- 水凝有效调节瘤微环境,提高抗瘤功效.
- 进一步开发基于水凝的癌症治疗方法对改善患者的治疗结果具有重大前景.
相关概念视频
Drug Therapy
302
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
302
Bioavailability Enhancement: Drug Solubility Enhancement
266
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
266
Bioavailability Enhancement: Drug Permeability Enhancement
211
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
211
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
224
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
224
Drug Delivery: Overview
900
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
900
Drug Delivery: Enteral Route
1.8K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.8K


